ArticleMedicine2026
Determinants and management approaches for fear of disease progression among stroke survivors.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to identify risk factors for fear of disease progression (FoP) among stroke survivors and propose management strategies. A cross-sectional study of 149 stroke patients (February 2022-March 2025) was conducted using the Fear of Progression Questionnaire-Short Form, Pittsburgh Sleep Quality Index, Social Support Rating Scale, and Family Adaptability and Cohesion Evaluation Scale II-Chinese Version. Pearson correlations and logistic regression were applied. Clinically significant FoP (≥34) was observed in 45.64% of patients. FoP positively correlated with poor sleep quality and negatively correlated with social support and family functioning (P < .001). Multivariate analysis identified neurological deficit severity, comorbidities, unemployment, and sleep disturbance as risk factors, while older age and higher social support were protective factors. FoP is prevalent among stroke survivors and is associated with sleep quality and social support. Targeted psychosocial and sleep-focused interventions may help reduce FoP.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.